The CollabRx Story
CollabRx applies collaborative science to slash the time, cost and risk of therapy development.
BACK TO TOP
CollabRx builds and operates Virtual Biotechs for foundations and patients who urgently seek cures for their diseases. Working with these foundations and research institutions, CollabRx
- builds teams of top researchers
- facilitates planning of a strategic road map
- brings best practices to therapy development
- manages the execution of the plan
Managing the precious resource of time
CollabRx enables teams of scientists to work collaboratively and with urgency, by aligning incentives and clearing obstacles.
CollabRx helps the research team explore the opportunity space of targets and leads in a systematic fashion by prioritizing projects and experiments based on all available knowledge. The team then implements workflows to achieve strategic milestones, spinning off tasks to third party services and tracking the whole process with real time dashboards.
CollabRx enables teams of scientists to work collaboratively and with urgency, by aligning incentives and clearing obstacles.
CollabRx helps the research team explore the opportunity space of targets and leads in a systematic fashion by prioritizing projects and experiments based on all available knowledge. The team then implements workflows to achieve strategic milestones, spinning off tasks to third party services and tracking the whole process with real time dashboards.
Leveraging the world’s knowledge
Virtual biotechs combine revolutionary advances in computational and high throughput biology with Web-based collaborative science to slash the time, cost and risk of therapy development.
The platform accelerates the research cycle by tightly integrating knowledge, decisions and actions. Knowledge, from experimental data, scientific literature, and community discourse, drives decisions about what to do next, which trigger workflows that generate new knowledge.
Virtual biotechs combine revolutionary advances in computational and high throughput biology with Web-based collaborative science to slash the time, cost and risk of therapy development.
The platform accelerates the research cycle by tightly integrating knowledge, decisions and actions. Knowledge, from experimental data, scientific literature, and community discourse, drives decisions about what to do next, which trigger workflows that generate new knowledge.
Making the most of your investment
CollabRx virtual biotechs make it cost-effective for teams of academic researchers to conduct industrial scale research. Virtual biotechs can be set up quickly and inexpensively, and can immediately exploit an ecosystem of shared knowledge and services. CollabRx takes advantage of findings in related diseases, both building on their successes and learning from (and hence not repeating) their failed experiments.
CollabRx virtual biotechs make it cost-effective for teams of academic researchers to conduct industrial scale research. Virtual biotechs can be set up quickly and inexpensively, and can immediately exploit an ecosystem of shared knowledge and services. CollabRx takes advantage of findings in related diseases, both building on their successes and learning from (and hence not repeating) their failed experiments.
The power of network effects
CollabRx rapidly develops new treatments by leveraging a distributed network of scientists, research labs, clinicians and contract research organizations. The CollabRx ecosystem includes centers of excellence in services such as
CollabRx rapidly develops new treatments by leveraging a distributed network of scientists, research labs, clinicians and contract research organizations. The CollabRx ecosystem includes centers of excellence in services such as
- genomic and proteomic profiling
- combinatorial drug screening
- mouse assembly lines
- cell culturing
- biostatistics
- data mining
CollabRx Research Platform
CollabRx virtual biotechs build upon a Web-based collaborative research platform that enables participants to discover, access, integrate, and share the resources they need. This platform combines elements of a data and knowledge sharing hub, search engine, workflow engine, ecommerce site, and collaborative workspace. Foundations and research teams use it to:
CollabRx virtual biotechs build upon a Web-based collaborative research platform that enables participants to discover, access, integrate, and share the resources they need. This platform combines elements of a data and knowledge sharing hub, search engine, workflow engine, ecommerce site, and collaborative workspace. Foundations and research teams use it to:
- Manage and track research operations
- Prioritize goals, tasks, and resources based on results
- Share data, knowledge, resources and services
- Connect hypotheses, evidence, decisions and goals
- Coordinate the use of bio-informatics
- Collaborate on data analysis
- Plan, automate and track workflows
- Seamlessly integrate external services
- Engage in continuous learning and process improvement
Therapy Development in the Networked Age
CollabRx aims to transform the life sciences industry — by connecting research labs, biotechs, pharmas and their service providers into a networked ecosystem of interoperable research services that can be rapidly assembled to develop new therapies with unprecedented efficiencies and economies of scale.
Our mission is finding treatments for rare and orphan diseases within the lifetimes and collective means of current patients. Today there are over 6,000 such diseases identified, afflicting over 25 million people. In the coming age of personalized genomic medicine, every disease will be rare and every individual’s condition unique.
Our partner foundations are already benefiting from our collaborative research process. Please contact us so we can meet and evaluate your specific needs.
CollabRx aims to transform the life sciences industry — by connecting research labs, biotechs, pharmas and their service providers into a networked ecosystem of interoperable research services that can be rapidly assembled to develop new therapies with unprecedented efficiencies and economies of scale.
Our mission is finding treatments for rare and orphan diseases within the lifetimes and collective means of current patients. Today there are over 6,000 such diseases identified, afflicting over 25 million people. In the coming age of personalized genomic medicine, every disease will be rare and every individual’s condition unique.
Our partner foundations are already benefiting from our collaborative research process. Please contact us so we can meet and evaluate your specific needs.
BACK TO TOP